Navigation Links
Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322

WALTHAM, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Adnexus(TM) Therapeutics, Inc. today announced the presentation of the abstract "CT-322: A specific VEGFR-2-blocking protein therapeutic agent with activity in preclinical tumor models comparable to pan-specific tyrosine kinase receptor inhibitors sunitinib and sorafenib" at the American Association for Cancer Research (AACR) 2007 annual meeting in Los Angeles, CA. The lead author is Irvith Carvajal, Ph.D., with Eric Furfine, Ph.D., senior vice president of research and preclinical development at Adnexus, presenting at the meeting.

CT-322 is a mono-specific blocker of the tyrosine kinase receptor, VEGFR-2, and blocks its activation by all known extracellular ligands; VEGF-A, VEGF-C, and VEGF-D. VEGFR-2 activation is the primary driver of tumor angiogenesis. In preclinical tumor models, CT-322 was compared to two approved pan-kinase inhibitors sunitinib and sorafenib. CT-322, sunitinib, and sorafenib each demonstrated comparable tumor growth suppression; however, CT-322 was better tolerated in the animal models.

"Our results suggest that 'pan-specific' kinase inhibitors may not offer improvement in anti-angiogenic induced tumor suppression over an extracellular, mono-specific blocker of VEGFR-2," commented Dr. Furfine. "CT-322's high affinity and selectivity for VEGFR-2 achieved comparable anti-tumor effect to molecules that inhibit a broad range of kinases."

"As cancer therapy evolves, the importance of efficacy, safety and tolerability of anti-angiogenic agents are becoming more pronounced due to the desire for combination therapy as well as longer duration of anti-angiogenic therapy," commented John Mendlein, Ph.D., chief executive officer of Adnexus. "We continue to extend our understanding of the VEGFR-2 pathway in tumor settings and its activation by VEGF-A, C and D. We are very encouraged by the emerging CT-322 Phase 1 data, and we look forward
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:7/24/2014)... , July 24, 2014  Restore Health, a ... compounded pharmaceuticals, announced that it is now offering ... to each individual based upon their particular genetic ... understanding the interaction between a patient,s genetics and ... very excited to provide this new service to ...
(Date:7/24/2014)... Inc. (NASDAQ: UPI ), a medical device ... products to treat voiding dysfunctions, today reported financial ... 30, 2014.  Global revenue for the ... to $4.1 million, as compared to $3.4 million ... Total revenue for the fiscal first quarter of ...
(Date:7/24/2014)... 2014  IRIDEX Corporation (NASDAQ: IRIX ) ... 2014 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, July 31, 2014 to ... developments. Interested parties may access the live ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... N.Y., Sept. 29 International Business ... (MHIN) will jointly present the 7th Annual MidAmerica ... Wisconsin Technology Council. The conference brings together ... corporate business development executives, angel investors, investment bankers, ...
... Aesthetics, a science-based medical device company dedicated to the development ... has announced the appointment of Gordie Nye as ... founder of Zeltiq Aesthetics, who served as President since September ... the Board of Directors since 2006. Mr. Levinson will ...
Cached Medicine Technology:Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 2Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 3Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 4Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 3
(Date:7/25/2014)... According to the Liver Cirrhosis ... Vkool.com, this is a comprehensive guide that provides ... safe remedies for liver cirrhosis . This ...     Chapter 1: Liver Cirrhosis Bible & ... About Liver Basics ,     Chapter 3: Getting ...
(Date:7/24/2014)... (PRWEB) July 25, 2014 Journal ... be affected by the width of the alveolar ridge—an ... the implant. A variety of methods exist, each with ... augmentation techniques. The ridge-split graft is highlighted as a ... Journal of Oral Implantology offers a comparison of ...
(Date:7/24/2014)... PROVIDENCE, R.I. [Brown University] The U.S. Preventive ... lung screening for people at high risk for ... that many patients will have positive results on ... on further testing. Many policymakers have expressed concern ... to become needlessly upset. A new study of ...
(Date:7/24/2014)... Voted one of the most reliable online ... focuses on providing its new and old customers with ... company has announced its new collection of high end ... created according to the latest fashion trends. Additionally, they ... off. , As a matter of fact, high end ...
(Date:7/24/2014)... 24, 2014 Four Seasons Resort ... of its $3 million renovation of the famed Maile ... three-bedroom suites, just in time to welcome summer guests ... design direction from the internationally-acclaimed BraytonHughes Design Studios, San ... the property and the largest in Hawaii—received a complete ...
Breaking Medicine News(10 mins):Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 3Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 2Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 3Health News:Informed consent: False positives not a worry in lung cancer study 2Health News:Informed consent: False positives not a worry in lung cancer study 3Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 5
... reporting assembly of the first functioning prototype of an ... process and package hormones, enzymes, and other substances that ... could lead to a faster and safer method for ... the researchers note. Their study is scheduled for the ...
... of the remains of a Tyrannosaurus rex (T. rex) ... protein from blood and bone, tendons, or cartilage. The findings, scheduled ... Journal of Proteome Research , is the latest addition to an ... dino. In the study, Marshall Bern, Brett S. Phinney and ...
... , , ... , , PRINCETON, N.J., July ... patient health and well-being, mentor less experienced staff, maintain institutional ... ages, creating a greater demand for hospital care, retaining veteran ...
... , , WASHINGTON , ... leading not-for-profit health plan and health care provider, received a 2009 ... and Prevention for its groundbreaking obesity prevention efforts. The award ... Washington, D.C., the CDC,s inaugural conference on obesity prevention and control. ...
... , WASHINGTON, July 29 Eight organizations were ... Control and Prevention (CDC) Weight of the Nation Conference in Washington, ... advancing policies and environmental strategies to prevent and control obesity. , ... particularly those from certain racial and ethnic groups, the CDC recognizes ...
... , , , BETHLEHEM, Pa., ... it has entered a new agreement with B. Braun ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ) , , ... members , B. Braun,s award winning Introcan Safety(R) IV Catheter ...
Cached Medicine News:Health News:New Study Identifies Strategies to Retain Experienced Nurses as Nursing Shortage Looms & Nation's Health Care Needs Grow 2Health News:New Study Identifies Strategies to Retain Experienced Nurses as Nursing Shortage Looms & Nation's Health Care Needs Grow 3Health News:New Study Identifies Strategies to Retain Experienced Nurses as Nursing Shortage Looms & Nation's Health Care Needs Grow 4Health News:New Study Identifies Strategies to Retain Experienced Nurses as Nursing Shortage Looms & Nation's Health Care Needs Grow 5Health News:New Study Identifies Strategies to Retain Experienced Nurses as Nursing Shortage Looms & Nation's Health Care Needs Grow 6Health News:Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 2Health News:Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 3Health News:Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 4Health News:CDC Recognizes Innovative Obesity Prevention and Control Initiatives With Weight of the Nation Awards 2Health News:CDC Recognizes Innovative Obesity Prevention and Control Initiatives With Weight of the Nation Awards 3Health News:CDC Recognizes Innovative Obesity Prevention and Control Initiatives With Weight of the Nation Awards 4Health News:New Agreement Between Amerinet and B. Braun 2
... is the premium CPAP device in ResMeds new ... line of flow generators are the smallest on ... to include an option of fully integrated heated ... for simplicity and convenience. Premium S8 models also ...
... freedom and flexibility with the integrated ... battery pack, the system will be ... Also includes an integrated heated humidifier. ... water for one nights use, and ...
... is the smallest and lightest continuous positive ... It is designed to help active sleep ... with therapy. The GoodKnight 420S model records ... data. It also detects persistent residual apnea, ...
The clarity and performance of glass with shatterproof safety of plastic....
Medicine Products: